Results 261 to 270 of about 7,567,038 (395)

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

open access: yesMolecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz   +15 more
wiley   +1 more source

Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1

open access: yesMolecular and Cellular Biology, 1996
Jo A. Forsythe   +6 more
semanticscholar   +1 more source

Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway

open access: yesMolecular Oncology, EarlyView.
Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed   +10 more
wiley   +1 more source

An improved reporter gene assay for evaluating the biological activity of recombinant human growth hormone. [PDF]

open access: yesJ Pharm Anal
Zhang X   +10 more
europepmc   +1 more source

Analysis of Dip2B Expression in Adult Mouse Tissues Using the LacZ Reporter Gene. [PDF]

open access: yesCurr Issues Mol Biol, 2021
Sah RK   +9 more
europepmc   +1 more source

A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.

open access: yesProceedings of the National Academy of Sciences of the United States of America, 1995
O. Boussif   +6 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy